WINTON GROUP Ltd bought a new position in Nextgen Healthcare Inc (NASDAQ:NXGN) in the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor bought 11,838 shares of the company’s stock, valued at approximately $236,000.
Several other institutional investors and hedge funds also recently modified their holdings of the company. Parallel Advisors LLC acquired a new stake in Nextgen Healthcare during the 1st quarter valued at $26,000. MERIAN GLOBAL INVESTORS UK Ltd acquired a new stake in Nextgen Healthcare during the 1st quarter valued at $109,000. Convergence Investment Partners LLC acquired a new stake in Nextgen Healthcare during the 1st quarter valued at $152,000. Squarepoint Ops LLC acquired a new stake in Nextgen Healthcare during the 4th quarter valued at $179,000. Finally, Piedmont Investment Advisors Inc. increased its holdings in Nextgen Healthcare by 6.0% during the 1st quarter. Piedmont Investment Advisors Inc. now owns 12,189 shares of the company’s stock valued at $205,000 after purchasing an additional 694 shares in the last quarter. 69.52% of the stock is owned by institutional investors and hedge funds.
In other Nextgen Healthcare news, Director Sheldon Razin sold 4,018 shares of the stock in a transaction on Thursday, June 13th. The stock was sold at an average price of $19.06, for a total value of $76,583.08. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, Director George H. Bristol sold 13,873 shares of the stock in a transaction on Monday, June 3rd. The shares were sold at an average price of $19.25, for a total value of $267,055.25. The disclosure for this sale can be found here. Insiders sold a total of 19,004 shares of company stock worth $364,819 over the last quarter. Corporate insiders own 18.50% of the company’s stock.
Nextgen Healthcare (NASDAQ:NXGN) last announced its quarterly earnings data on Wednesday, July 24th. The company reported $0.10 EPS for the quarter, missing the Zacks’ consensus estimate of $0.15 by ($0.05). The firm had revenue of $131.86 million during the quarter, compared to the consensus estimate of $136.33 million. Nextgen Healthcare had a net margin of 4.37% and a return on equity of 10.05%. The firm’s quarterly revenue was down 1.0% on a year-over-year basis. During the same quarter in the previous year, the business posted $0.19 earnings per share. On average, equities analysts expect that Nextgen Healthcare Inc will post 0.62 earnings per share for the current fiscal year.
A number of equities research analysts recently weighed in on the company. Zacks Investment Research cut Nextgen Healthcare from a “hold” rating to a “sell” rating and set a $17.00 price target for the company. in a report on Tuesday, July 30th. Leerink Swann raised Nextgen Healthcare from a “market perform” rating to an “outperform” rating in a report on Thursday, April 25th. Svb Leerink raised Nextgen Healthcare from a “market perform” rating to an “outperform” rating and raised their price target for the company from $19.00 to $22.00 in a report on Thursday, April 25th. ValuEngine raised Nextgen Healthcare from a “hold” rating to a “buy” rating in a report on Thursday. Finally, Dougherty & Co cut Nextgen Healthcare from a “neutral” rating to a “sell” rating in a report on Thursday, July 25th. Three investment analysts have rated the stock with a sell rating, one has given a hold rating and four have assigned a buy rating to the company. Nextgen Healthcare presently has an average rating of “Hold” and an average price target of $18.83.
Nextgen Healthcare Company Profile
NextGen Healthcare, Inc provides software, services, and analytics solutions to medical and dental group practices in the United States. The company's principal products include NextGen Enterprise EHR, which stores and maintains clinical patient information; and a workflow module, prescription management, automatic document and letter generation, patient education, referral tracking, interfaces to billing and lab systems, physician alerts and reminders, and reporting and data analysis tools.
Further Reading: Arbitrage
Want to see what other hedge funds are holding NXGN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Nextgen Healthcare Inc (NASDAQ:NXGN).
Receive News & Ratings for Nextgen Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nextgen Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.